Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2262422
Max Phase: Preclinical
Molecular Formula: C12H20O4
Molecular Weight: 228.29
Molecule Type: Small molecule
Associated Items:
ID: ALA2262422
Max Phase: Preclinical
Molecular Formula: C12H20O4
Molecular Weight: 228.29
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC(=O)OCC1CC(CC)(CC)C(=O)O1
Standard InChI: InChI=1S/C12H20O4/c1-4-10(13)15-8-9-7-12(5-2,6-3)11(14)16-9/h9H,4-8H2,1-3H3
Standard InChI Key: PKFSEISCQAQPRK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 228.29 | Molecular Weight (Monoisotopic): 228.1362 | AlogP: 2.06 | #Rotatable Bonds: 5 |
Polar Surface Area: 52.60 | Molecular Species: | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.65 | CX LogD: 2.65 |
Aromatic Rings: 0 | Heavy Atoms: 16 | QED Weighted: 0.68 | Np Likeness Score: 0.84 |
1. Ahungena A, Canney DJ. (2005) Synthesis and Evaluation of Homologous Analogs of Anticonvulsant 5-Substituted 3,3-Diethyl-4,5-Dighdro-2(3H)-Furanones, 14 (7): [10.1007/s00044-006-0144-4] |
Source(1):